Effect of atorvastatin on dyslipidemia and carotid intima-media thickness in children with refractory nephrotic syndrome: a randomized controlled trial

ConclusionsAtorvastatin, administered at a fixed daily dose of 10  mg, was not beneficial in lowering lipid levels in children with SRNS; rise in serum albumin was associated with improvement in dyslipidemia.
Source: Pediatric Nephrology - Category: Urology & Nephrology Source Type: research